Executive SummaryRaises additional $5.3 mil. through private placement with European venture capitalists. Financing came from Scandinavia firm A.S. Industriforsikring and from Hambrecht & Quist Life Science Ventures, Hambrecht & Quist London, Delphi BioInvestments, Technology Funding Partners III, Ventana Growth Fund, Cabanco Fondkommission and Elf Technology. Telios has raised $22 mil. to date in addition to support received from Ono.
You may also be interested in...
The EU network of health technology assessment bodies says it is seeing the benefit of systematically involving patients when companies approach it for early scientific advice on evidence generation.
As stockpiles of Ebola vaccine are being built up around the world, Médecins sans Frontières has said more action is needed to ensure sufficient numbers of vaccinations are available for use in current and future outbreaks.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced November 2019.